Brain Glucose Metabolism in Cerebral Amyloid Angiopathy: An FDG-PET Study.

Background and Purpose: The in vivo diagnosis of cerebral amyloid angiopathy (CAA) is currently based on the Boston criteria, which largely rely on hemorrhagic features on brain magnetic resonance imaging. Adding to these criteria 18F-fluoro-deoxy-D-glucose (FDG) positron emission tomography, a wide...

Descripción completa

Detalles Bibliográficos

Publicado en:	Stroke (00392499) Vol. 52; no. 4; pp. 1478 - 1483
Autores principales:	Bergeret, Sébastien, Queneau, Mathieu, Rodallec, Mathieu, Landeau, Brigitte, Chetelat, Gaël, Hong, Young T., Dumurgier, Julien, Hugon, Jacques, Paquet, Claire, Farid, Karim, Baron, Jean-Claude
Formato:	research Journal Article
Publicado:	Lippincott Williams & Wilkins Apr2021
Acceso en línea:	Ver este registro en EBSCOhost